Element Pointe Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Element Pointe Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,636	Closed	-$275K	–	110
2021 Q2	$275K	Hold	1,636	–	–	0.08%	98
2021 Q1	$262K	Hold	1,636	–	–	0.09%	103
2020 Q4	$275K	Hold	1,636	–	–	0.1%	93
2020 Q3	$257K	Hold	1,636	–	–	0.11%	96
2020 Q2	$274K	Hold	1,636	–	–	0.14%	79
2020 Q1	$214K	Sell	1,636 -131	-7%	-$18.7K	0.13%	73
2019 Q4	$263K	Hold	1,767	–	–	0.14%	75
2019 Q3	$219K	Hold	1,767	–	–	0.13%	82
2019 Q2	$249K	Hold	1,767	–	–	0.14%	78
2019 Q1	$267K	Buy	+1,767	New	+$254K	0.16%	61

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Element Pointe Advisors's FBT Position: Q3 2021 in Review

Element Pointe Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2021, closing a stake of 1,636 shares — an estimated $275K sold.

Element Pointe Advisors first reported a position in FBT in Q1 2019 and held it in 10 quarters. The position peaked at $275K in Q2 2021. 236 funds tracked by Wall St. Rank hold FBT as of Q3 2021.

Element Pointe Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2021 after selling out during the quarter.
Element Pointe Advisors sold 1,636 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2021, an estimated $275K.
Element Pointe Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and held it in 10 quarters.
Element Pointe Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $275K in Q2 2021.
236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2021.

Based on Element Pointe Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.